Activated mast cells release a large range of potent mediators of allergic inflammation, including proteases. The tryptase serum levels were evaluated in 13 subjects suffering from allergic perennial rhinitis. Moreover, the effects of cetirizine treatment on serum tryptase were studied using the UniCap™ tryptase fluoroenzymeimmunoassay.
In allergic patients the serum tryptase values (M±SD: 6.1 ± 2.4 μg/L) were significantly (p < 0.02) higher than the values detected in controls (3.0 ± 1.2 μg/L). In allergic rhinitis, after antihistamine treatment, tryptase values (4.4 ± 1.8 μg/L) decreased significantly (p < 0.001). After two weeks from the cetirizine stop, the tryptase levels increased again (5.5 ± 2.6 μg/l).
The results demonstrate that mast cells are constantly activated in perennial allergic rhinitis. The antihistamine treatment is effective in reducing the tryptase release from mast cells, but the mechanism of action of cetirizine is still to understand.
References
1.
MygindN. and DahlR.. 1996. Epidemiology of allergic rhinitis. Pediatr. Allergy Immunol.7:57.
2.
MeltzerE.O.1997. The pharmacological basis for the treatment of perennial allergic rhinitis and non-allergic rhinitis with topical corticosteroids. Allergy52 (36):33.
3.
BroideO.H., EismanS., RamsdellI.W., FergusonP., SchwartzL.B.WassermanS.I.. 1990. A bronchoalveolar lavage study of mast cell derived mediators in exercise induced asthma. Ann. Rev. Respir. Dis.141:563.
4.
CastellsM.C. and SchwartzL.B.. 1988. Tryptase levels in nasal lavage fluid as an indicator of the immediate allergic response. J. Allergy Clin. Immunol.82:348.
5.
SchwartzL.B., AtkinsP.C., BradfordT.R., FleecopP., ShalitN. and ZweimanB.. 1987. Release of tryptase together with histamine during the immediate cutaneous response to allergen. J. Allergy Clin. Immunol.80:850.
6.
ButrusS.I., OchsnerK.I., AbelsonM.E. and SchwartzL.B.. 1990. The levels of tryptase in human tears: an indicator of activation of conjunctival mast cells. Ophtalmol.97:1678.
7.
MagriniL., BoniniS., CentofantiM., SchiavoneM. and BoniniS.. 1996. Tear tryptase levels and allergic conjunctivitis. Allergy51:577.
8.
WongD., ClementP., SmitzJ. and De WaeleM.. 1996. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis. Acta Otorhinolaryngol. Belg.50:25.
9.
SchwartzL.B.1994. Tryptase: a mast cell serine protease. In Methods in Enzymology, Proteolytic Enzymes: Serine and Cystine Peptidase.BarrettA.J. ed., Academic PressNew York, p. 88.
10.
MariA., LucentiniL., ParoliM., FranceschiniP. and BrunoG.. 1984. Prevention of multiple manifestation in allergic respiratory diseases. Clinical relevance of early diagnosis. In: Proc. Inter. Symposium on Prevention of Allergic Diseases, Florence, June 24-27, p. 187.
11.
ToccaceliF., RotiglianoG., BrunoG., ManciniG., VaccaF. and BoniniS.. 1981. Occurrence of asthma in patients with allergic rhinitis. Prognostic value of clinical and laboratory tests. Respiration42:77.
12.
SchwartzLB. and AustenK.F.. 1988. The mast cell and mediators of immediate hypersensitivity. In Immunological Diseases.SamterM., TalmageD.W., FrankM.M., ClamanH.N. eds, Little Brown & Co, Boston, p. 157.
13.
CastellsMC, IraniA.M. and SchwartzL.B.. 1987. Evaluationb of human Peripheral Blood Leuccytes for mast cell tryptase. J. Immunol.138:2184.
14.
SchwartzL.B., YungingerJ.W., MillerJ.S., BokhariR. and DullD.. 1989. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J. Clin. Invest.83:1551.
15.
SchwartzLB., MetcalfD.D., MillerJ.S., EarlH. and SullivanT.. 1987. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N. Engl. J. Med.316:1622.
16.
HowartP.H. and HolmbergK.. 1995. Allergic rhinitis: an increasing clinical problem. Allergy50:4.
17.
Rowe-JonesJ.M.1997. The link between nose and lung, perennial rhinitis and asthma - is it the same disease?Allergy52:20.
18.
SmithJ.M.1993. Epidemiology. In Allergic and non allergic rhinitis.MygindN., NaclerioR.M. ed. Mnksgaard, Copenhagen, p. 1.
19.
HorakF. and StubnerU.P.. 1998. New trends in allegic rhinitis. ACI Int.10:81.
20.
SimonsF.E.R.1998. Allergic rhinitis and asthma. ACI Int.10:204.
21.
BoniniS., ManciniG., BrunoG., ToccaceliF., SacerdoteM.T. and MasalaC.. 1977. Subclinical bronchial obstruction in pure allergic rhinitis. In Proc Xth EAACI Cong. 18..
22.
ToccaceliF., RotiglianoG., BrunoG., ManciniG., VaccaF. and BoniniS.. 1981. Occurrence of asthma in patients with allergic rhinitis. Prognostic value of clinical and laboratory tests. Respiration42:77.
23.
FasceL., CiprandiG., PronzatoC., CozzaniS., ToscaM.A., GrimaldiI. and CanonicaG.W.. 1996. Cetirizine reduces ICAM-1 expression on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite allergic asthma. Int. Arch. Allergy Immunol.109:272.
24.
JosephM., VorngH., LassalleP., TsicopoulosA., de VosC., CapronA., . 1989. In vitro activity of cetirizine on platelets. Health Science Review3:8.
25.
LusterA.D. and RothenbergM.E.. 1997. Role of thew monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukoc. Biol.62:620.
26.
AndreozziP., MagriniL., BagalinoA., ZainoS., GrafU. and BrunoG.. 1998. Effects of antihistamine treatment on serum RANTESlevels Allergologie10:519.
27.
AndreozziP., MagriniL., BagalinoA., GrafU., ZainoS. and BrunoG.. 1998. MCP-1 chemokine in allergic rhinitis. Effect of anti-histamine treatment. In Proc. Interasma, Marrakech, (Marocco) p. 25.
28.
CharlesworthE.N., Kagey-SobotkaA., NormanP.S. and LichtensteinL.M.. 1989. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J. Allergy Clin. Immunol.83:905.
29.
NaclerioRM., ProudD. and TogiasA.G.. 1985. Inflammatory mediators in late antigen-induced rhinitis. N. Eng. J. Med.313:65.
30.
FadelR., DavidB., Heprin-RichardN., BorgnonA., RassemontR. and RihouxJ.P.. 1990. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet activating factor in man. J. Allergy Clin. Immunol.86:314.
31.
Campoli-RichardsD.M., BuckleyM.M.-T. and FittonA.. 1990. Cetirizine. A review of its pharmacological properties in allergic rhinitis, pollen-induced asthma and chronic urticaria. Drugs40:762.
32.
MasiM., CandianiR. and van de VenneH.. 1993. A placebo-controlled trial of cetirizine in seasonal allergic rhino-conjunctivitis in children aged 6 to 12 years. Pediatr. Allergy Immunol.4:47.
33.
CharlesworthE.N.1997. The role of basophils and mast cells in acute and late phase reaction in the skin. Allergy52:31.
34.
BrunoG., RovinaR., CelestinoD., PellegriniM.A., ToccaceliF. and ErrigoE.. 1981. Valutazione in doppio cieco degli effetti dell'astemizolo nel trattamento della rinopatia allergica. Progr. Med.37:856.
35.
BrunoG., ErrigoE., Del GiaccoG.S., LocciS., MelilloG. and D'AmatoG.. 1986. A multicentre study to evaluate the efficacy and safety of 8W825C (Acrivastine) in the treatment of seasonal allergic rhinitis. Eur. Rev. Pharmacol. Sci.3:305.
36.
BrunoG., D'AmatoG., Del GiaccoG.S., LocciF., GaleN.M., ErrigoE. and MelilloG.. 1989. Prolonged treatment with acrivastine for seasonal allergic rhinitis. J. Intern. Med. Res.17:40B.
37.
BrunoG., BioccaM.M., AlbiniF., AllegrucciA. and BalsanoF.. 1991. Antihistamines in the treatment of allergic respiratory diseases. Allergy Digest.5:12.
